Alexandria Venture Healthcare News

Follow[dot]Health is a news alert service for Heathcare and Healthtech. We are following 40K entities across 30M news items - with 1M items added monthly. This is selected healthcare news for Alexandria Venture, which is filed under Capital Firms. There are 567 news items for this page.

Please provide a valid email address.

Selected Headlines

Date Headline (link) Source
6/23/2022 Go ask Alice: Eat me and don’t eat me signals at the heart of DEM Biopharma | BioWorld
... is Jan Skvarka, Trillium Therapeutics Inc.’s former CEO. Longwood Fund and Alta Partners led the financing with participation from Insight Partners, Pfizer Ventures, Astellas Venture Management, Emerson Collective, Utokyo Innovation Platform and Alexandria Venture Investments. Low-dose HD gene therapy cohort in Uniqure phase I/II excites Street Uniqure ...
BioWorld
6/23/2022 DEM BioPharma Launches with $70 Million Financing
... today announced its initial $70 million financing led by founding investor Longwood Fund and Alta Partners , with additional participation from Insight Partners , Pfizer Ventures , Astellas Venture Management , Emerson Collective , UTokyo Innovation Platform and Alexandria Venture Investments . DEM Bio is pioneering the next generation of immunotherapeutics designed to unleash macrophages and ...
Business Wire
6/8/2022 Pleno ‘Hypercoding’ Poised to Disrupt Clinical Testing
... using principles derived from the telecommunications industry has attracted interest from investors and industry veterans alike. Last month, the company announced a $15 million Pre-series A led by Medical Excellence Capital and Alexandria Venture Investments. Pleno also announced it had appointed to chair of its board of directors, biotech ...
sdbj.com
5/27/2022 Inspirna to Present Phase 1b RGX-202-01 Clinical Trial Data at the 2022 American Society of Clinical Oncology (ASCO) Annual Meeting Business Wire
5/26/2022 Stablix Appoints Eddine Saiah Chief Scientific Officer and Expands Leadership Team Business Wire
5/25/2022 Multiomics startup Pleno nabs $15M for a telecom-based approach to analyzing DNA, RNA | Fierce Biotech FierceBiotech
5/25/2022 Multi-omics Startup Pleno Inc. Announces $15 Million in Pre-Series A Funding Yahoo News
5/25/2022 Multi-omics Startup Pleno Inc. Announces $15 Million in Pre-Series A Funding pharmaceuticaldaily.com
4/26/2022 Pheast Raises $76M in Series A Funding to Train the Immune System to Feast on Cancer PR Newswire
3/31/2022 Alexandria Venture Investments Recognized as One of the Top Five Most Active U.S. Investors in Agrifoodtech for Second Consecutive Year | Insider Tracking insidertracking.com
3/31/2022 Alexandria Venture Investments Recognized as One of the Top Five Most Active U.S. Investors in Agrifoodtech for Second Consecutive Year | 2022-03-31 | Press Releases | Stockhouse stockhouse.com
3/31/2022 Alexandria Venture Investments Recognized as One of the Top Five Most Active U.S. Investors in Agrifoodtech for Second Consecutive Year PR Newswire
3/31/2022 Alexandria Venture Investments Recognized as One of the Top Five Most Active U.S. Investors in Agrifoodtech for Second Consecutive Year globalbankingandfinance.com
3/22/2022 Affini-T raises $175M with help from Bayer to develop T-cell treatments | BioWorld BioWorld
3/22/2022 Affini-T Therapeutics Completes $175 Million Financing Co-Led by Vida Ventures and Leaps by Bayer to Advance Groundbreaking T Cell Therapies for Solid Tumor Patients with Oncogenic Driver Mutations Business Wire
3/22/2022 Affini-T Therapeutics Completes $175 Million Financing Co-Led by Vida Ventures and Leaps by Bayer to Advance Groundbreaking T Cell Therapies for Solid Tumor Patients with Oncogenic Driver Mutations Yahoo News
3/21/2022 Worldwide Gene Editing Beyond CRISPR Industry to 2035 - Featuring Amgen Ventures, ArrowMark Partners and Baxter Ventures Among Others - ResearchAndMarkets.com Business Wire
3/21/2022 Worldwide Gene Editing Beyond CRISPR Industry to 2035 - Featuring Amgen Ventures, ArrowMark Partners and Baxter Ventures Among Others - ResearchAndMarkets.com Yahoo News
3/15/2022 Eclipsebio Announces a $14 Million Series A Financing to Advance Its RNA Genomics Technology Platform PR Newswire
2/15/2022 Kallyope scores $236M, Ro scoops up $150M and more digital health fundings MobiHealthNews
2/15/2022 Terray Therapeutics Launches with $60M to Deliver Premium Chemical Data at Unrivaled Scale, Unlocking the Potential of AI-Driven Small Molecule Drug Discovery PR Newswire
1/28/2022 Alexandria Venture Investments Commits Over $100M to Climate Change Technology Related Investments in 2021 globalbankingandfinance.com
1/10/2022 Maze Therapeutics Announces $190 Million Financing to Support the Advancement of Nine Precision Medicine Programs and Compass Platform for Genetically Defined Diseases Yahoo News
1/10/2022 Maze Therapeutics Announces $190 Million Financing to Support the Advancement of Nine Precision Medicine Programs and Compass Platform for Genetically Defined Diseases | Business Wire Business Wire
1/10/2022 Maze Therapeutics Announces $190 Million Financing to Support the Advancement of Nine Precision Medicine Programs and Compass Platform for Genetically Defined Diseases Business Wire